[1] Choby B. Diabetes Update: Prevention and Management of Diabetes Complications. FP essentials. 2017; 456: 36-40.
[2] Zhao YF, Wang ZQ, Yang J, Wang LM, Zhao ZP, Zeng XY, et al. [Prevalence, awareness, status of treatment and control on type 2 diabetes mellitus among Chinese premenopausal women aged 18-49 in 2013] . Zhonghua liu xing bing xue za zhi. 2018; 39(2): 213-7.
[3] Plötz T, Hartmann M, Lenzen S, Elsner M. The role of lipid droplet formation in the protection of unsaturated fatty acids against palmitic acid induced lipotoxicity to rat insulin-producing cells. Nutr Metab (Lond). 2016; 13: 16.
[4] Gaemers IC, Stallen JM, Kunne C, Wallner C, van Werven J, Nederveen A, et al. Lipotoxicity and steatohepatitis in an overfed mouse model for non-alcoholic fatty liver disease. Biochim Biophys Acta. 2011; 1812(4): 447-58.
[5] Roseman HM. Progression from obesity to type 2 diabetes: lipotoxicity, glucotoxicity, and implications for management. J Manag Care Pharm. 2005; 11(6): 3-11.
[6] Shapiro H, Theilla M, Attal-Singer J, Singer P. Effects of polyunsaturated fatty acid consumption in diabetic nephropathy. Nat Rev Nephrol. 2011; 7(2): 110-21.
[7] Murea M, Freedman BI, Parks JS, Antinozzi PA, Elbein SC, Ma L, et al. Lipotoxicity in diabetic nephropathy: the potential role of fatty acid oxidation. Clin J Am Soc Nephrol. 2010; 5(12): 2373-9.
[8] Stamatikos A, Dronadula N1, Ng P, et al. ABCA1 Overexpression in Endothelial Cells In Vitro Enhances ApoAI-Mediated Cholesterol Efflux and Decreases Inflammation. Hum Gene Ther. 2019; 30(2): 236-248.
[9] Stamatikos A, Dronadula N, Ng P, Palmer D, Knight E, Wacker BK, et al. ABCA1 deficiency and cellular cholesterol accumulation increases islet amyloidogenesis in mice. Diabetologia. 2016; 59(6): 1242-6.
[10] Wahrle SE, Jiang H, Parsadanian M, Kim J, Li A, Knoten A, et al. Overexpression of ABCA1 reduces amyloid deposition in the PDAPP mouse model of Alzheimer disease. J Clin Invest. 2008;118(2): 671-82.
[11] Joyce CW, Wagner EM, Basso F, Amar MJ, Freeman LA, Shamburek RD, et al. ABCA1 overexpression in the liver of LDLr-KO mice leads to accumulation of pro-atherogenic lipoproteins and enhanced atherosclerosis. J Biol Chem. 2006; 281(44): 33053-65.
[12] Liu P, Peng L, Zhang H, Tang PM, Zhao T, Yan M, et al. Tangshen Formula Attenuates Diabetic Nephropathy by Promoting ABCA1-Mediated Renal Cholesterol Efflux in db/db Mice. Front Physiol. 2018; 9: 343.
[13] Geyeregger R, Zeyda M, Stulnig TM. Liver X receptors in cardiovascular and metabolic disease. Cell Mol Life Sci. 2006; 63(5): 524-39.
[14] Boivin V, Deschamps-Francoeur G, Couture S, Nottingham RM, Bouchard-Bourelle P, Lambowitz AM, et al. Simultaneous sequencing of coding and noncoding RNA reveals a human transcriptome dominated by a small number of highly expressed noncoding genes. RNA. 2018; 24(7): 950-65.
[15]Lawrie CH, Armesto M, Fernandez-Mercado M, Arestín M, Manterola L, Goicoechea I, et al. Noncoding RNA Expression and Targeted Next-Generation Sequencing Distinguish Tubulocystic Renal Cell Carcinoma (TC-RCC) from Other Renal Neoplasms. J Mol Diagn. 2018; 20(1): 34-45.
[16] Talkish J, May G, Lin Y, Woolford JL Jr, McManus CJ. Mod-seq: high-throughput sequencing for chemical probing of RNA structure. RNA; 2014, 20(5): 713-20.
[17] Li Y, Syed J, Sugiyama H. RNA-DNA Triplex Formation by Long Noncoding RNAs. Cell Chem Biol. 2016; 23(11): 1325-33.
[18] Das S, Reddy MA, Senapati P, Stapleton K, Lanting L, Wang M, et al. Diabetes Mellitus-Induced Long Noncoding RNA Dnm3os Regulates Macrophage Functions and Inflammation via Nuclear Mechanisms. Arterioscler Thromb Vasc Biol. 2018; 38(8): 1806-20.
[19]Li D, Cheng M, Niu Y, Chi X, Liu X, Fan J, et al. Identification of a novel human long non-coding RNA that regulates hepatic lipid metabolism by inhibiting SREBP-1c. International journal of biological sciences. 2017; 13(3): 349-57.
[20] Matsuda J, Namba T, Takabatake Y, Kimura T, Takahashi A, Yamamoto T, et al. Antioxidant role of autophagy in maintaining the integrity of glomerular capillaries. Autophagy. 2018; 14(1): 53-65.
[21] Ahotupa M. Oxidized lipoprotein lipids and atherosclerosis. Free Radic Res. 2017; 51(4): 439-47.
[22] Yao Y, Wang Y, Zhang Y, Liu C. Klotho ameliorates oxidized low density lipoprotein (ox-LDL)-induced oxidative stress via regulating LOX-1 and PI3K/Akt/eNOS pathways. Lipids Health Dis. 2017; 16(1): 77.
[23] Tang L, Wang G, Jiang L, Chen P, Wang W, Chen J, et al. Role of sEH R287Q in LDLR expression, LDL binding to LDLR and LDL internalization in BEL-7402 cells. Gene. 2018; 667: 95-100.
[24] Bao S, Li Y, Lei X, Wohltmann M, Jin W, Bohrer A, et al. Attenuated free cholesterol loading-induced apoptosis but preserved phospholipid composition of peritoneal macrophages from mice that do not express group VIA phospholipase A2. J Biol Chem. 2007; 282(37): 27100-14.
[25] Ness GC. Physiological feedback regulation of cholesterol biosynthesis: Role of translational control of hepatic HMG-CoA reductase and possible involvement of oxylanosterols. Biochim Biophys Acta. 2015; 1851(5): 667-73.
[26] Honzumi S, Takeuchi M, Kurihara M, Fujiyoshi M, Uchida M, Watanabe K et al. The effect of cholesterol overload on mouse kidney and kidney-derived cells. Renal failure. 2018; 40(1): 43-50.
[27] Vaziri ND. Lipotoxicity and impaired high density lipoprotein-mediated reverse cholesterol transport in chronic kidney disease. J Ren Nutr. 2010; 20(5): 35-43.
[28]Zhang G, Li Q, Wang L, et al. Interleukin-1beta enhances the intracellular accumulation of cholesterol by up-regulating the expression of low-density lipoprotein receptor and 3-hydroxy-3-methylglutaryl coenzyme A reductase in podocytes. Mol Cell Biochem. 2011; 346(1-2): 197-204.
[29] Li CH, Gong D, Chen LY, Wang L, Zhang W. Puerarin promotes ABCA1-mediated cholesterol efflux and decreases cellular lipid accumulation in THP-1 macrophages. Eur J Pharmacol. 2017; 811: 74-86.
[30]Yin QH, Zhang R, Li L,Wang YT, Liu JP, Zhang J, et al. Exendin-4 Ameliorates Lipotoxicity-induced Glomerular Endothelial Cell Injury by Improving ABC Transporter A1-mediated Cholesterol Efflux in Diabetic apoE Knockout Mice. J Biol Chem. 2016; 291(51): 26487-501.
[31]Ignatova ID, Angdisen J, Moran E, et al. Differential regulation of gene expression by LXRs in response to macrophage cholesterol loading. Mol Endocrinol. 2013; 27(7): 1036-47.
[32] Lan X, Yan J, Ren J, Schulman IG. A novel long noncoding RNA Lnc-HC binds hnRNPA2B1 to regulate expressions of Cyp7a1 and Abca1 in hepatocytic cholesterol metabolism. Hepatology. 2016; 64(1): 58-72.
[33] Huang J, Chen S, Cai D, Bian D, Wang F. Long noncoding RNA lncARSR promotes hepatic cholesterol biosynthesis via modulating Akt/SREBP-2/HMGCR pathway. Life Sci. 2018; 203: 48-53.
[34] Sallam T, Jones M, Thomas BJ, Wu X, Gilliland T, Qian K, et al. Transcriptional regulation of macrophage cholesterol efflux and atherogenesis by a long noncoding RNA. Nat Med. 2018; 24(3): 304-12.
[35]Sallam T, Jones MC, Gilliland T, Zhang L, Wu X, Eskin A, et al. Feedback modulation of cholesterol metabolism by the lipid-responsive non-coding RNA LeXis. Nature. 2016; 534(7605): 124-8.